- Protocol Short Name and Number: Bexxar/BEAM,0401
- Protocol Long Name: Phase III Rituxan/BEAM vs. Bexxar/BEAM with Autologous Hematopoietic Stem Cell Transplantation (ASCT) for Persistent or Relapsed Chemotherapy Sensitive Diffuse Large B-Cell Non-Hodgkin’s Lymphoma
- Protocol (PDF)
- Informed Consent
- Frequently Asked Questions
- Key Personnel
- BMT CTN # 0401 Protocol Chair: Julie Vose, MD
- BMT CTN # 0401 Protocol Officer: Marcie Tomblyn, MD
- BMT CTN # 0401 Medical Monitor: Eneida Nemecek, MD
- BMT CTN # 0401 Protocol Coordinator: bmtctn@emmes.com
- Keywords: Bexxar, BEAM, Rituxan, Autologous Transplant, Auto Transplant, Auto, B-cell Lymphoma, Lymphoma, DLCBL
This study reached target accrual and closed to patient accrual on July 17, 2009.